Equity - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Jul. 31, 2020
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	280,000,000	280,000,000	280,000,000
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000	50,000,000
Common stock issued in connection with stock options exercised (in shares)			4,304
Common stock issued through the dividend reinvestment plan (in shares)			1,211	1,561
Number of shares of stock grants withheld (in shares)			69,834	74,726
Common stock issued through Employee Stock Purchase Plan (in shares)			9,307
Repurchases of shares (in shares)			0
Stock repurchase program, remaining authorized amount	$ 316,148,000		$ 316,148,000
2020 Stock Repurchase Program
Class of Stock [Line Items]
Stock repurchase program, authorized amount					$ 500,000,000
Continuous Equity Program CEP V
Class of Stock [Line Items]
Maximum value of shares of common stock that can be sold (in dollars)	$ 1,000,000,000		$ 1,000,000,000
Common stock sold under CEP V (in shares)	0		0
Forward contract indexed to issuer's equity (in shares)	2,000,000	68,577
Net proceeds of forward contract indexed to issuer's equity	$ 494,200,000	$ 16,000,000
Common stock value, remaining to be authorized under continuous equity program	$ 705,961,000		$ 705,961,000
Maximum | Continuous Equity Program CEP V
Class of Stock [Line Items]
Percentage of compensation received by sales agent			1.50%
Restricted Stock and Restricted Stock Converted from Performance Shares
Class of Stock [Line Items]
Equity instruments granted (in shares)			135,860	151,186
Restricted stock
Class of Stock [Line Items]
Equity instruments granted (in shares)			81,807	94,641
Stock issued during period, shares, share-based compensation, forfeited (in shares)			2,878	709